Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05802979Phase 3Unknown
Phase 3, randomised trial of ketamine and neostigmine in postoperative pain (3 arms), sponsored by Ain Shams University. Primary endpoint: Total Postoperative Nalbuphine Consumption at 24 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05802979.